Figure 3.
(A) Median recurrence-free survival (RFS) was 18.86 months for PD-L1 IHC-negative and 12.56 months for PD-L1 IHC-highly positive samples. (B) Median RFS was 18.66 months for PD-L1 RISH-positive and 15.20 months for PD-L1 RISH-negative.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.